Structure-activity relationship to investigate ligand selectivity for the acetylcholine binding site of the rat α4β2 and α3β4 nicotinic subtypes.

被引：0
|
作者：
Bisson, WH [1 ]
Westera, G [1 ]
Schubiger, PA [1 ]
Scapozza, L [1 ]
机构：
[1] Swiss Fed Inst Technol, Ctr Radiopharmaceut Sci, Dept Chem & Appl Biosci, CH-8091 Zurich, Switzerland
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
243-MEDI
引用
收藏
页码：U45 / U45
页数：1
相关论文
共 50 条
  • [21] Characterizing low affinity epibatidine binding to α4β2 nicotinic acetylcholine receptors with ligand depletion and nonspecific binding
    Person, Alexandra M.
    Wells, Gregg B.
    BMC BIOPHYSICS, 2011, 4
  • [22] Identifying the Binding Site of Novel Methyllycaconitine (MLA) Analogs at α4β2 Nicotinic Acetylcholine Receptors
    Quek, Gracia X. J.
    Lin, Diana
    Halliday, Jill I.
    Absalom, Nathan
    Ambrus, Joseph I.
    Thompson, Andrew J.
    Lochner, Martin
    Lummis, Sarah C. R.
    McLeod, Malcolm D.
    Chebib, Mary
    ACS CHEMICAL NEUROSCIENCE, 2010, 1 (12): : 796 - 809
  • [23] Identification of a Negative Allosteric Site on Human α4β2 and α3β4 Neuronal Nicotinic Acetylcholine Receptors
    Pavlovicz, Ryan E.
    Henderson, Brandon J.
    Bonnell, Andrew B.
    Boyd, R. Thomas
    McKay, Dennis B.
    Li, Chenglong
    PLOS ONE, 2011, 6 (09):
  • [24] Selectivity of ( ± )-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular α3β4*and α9α10 subtypes
    Arias, Hugo R.
    Jin, Xiao-Tao
    Gallino, Sofia
    Peng, Can
    Feuerbach, Dominik
    Garcia-Colunga, Jesus
    Belen Elgoyhen, Ana
    Drenan, Ryan M.
    Ortells, Marcelo O.
    NEUROCHEMISTRY INTERNATIONAL, 2019, 131
  • [25] Novel α3β4 Nicotinic Acetylcholine Receptor-Selective Ligands. Discovery, Structure-Activity Studies, and Pharmacological Evaluation
    Zaveri, Nurulain
    Jiang, Faming
    Olsen, Cris
    Polgar, Willma
    Toll, Lawrence
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 8187 - 8191
  • [26] Non-Equivalent Ligand Selectivity of Agonist Sites in (α4β2) 2α4 Nicotinic Acetylcholine Receptors: A Key Determinant of Agonist Efficacy
    Mazzaferro, Simone
    Gasparri, Federica
    New, Karina
    Alcaino, Constanza
    Bermudez, Isabel
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 429A - 429A
  • [27] Complementary Three-Dimensional Quantitative Structure-Activity Relationship Modeling of Binding Affinity and Functional Potency: A Study on α4β2 Nicotinic Ligands
    Tosco, Paolo
    Ahring, Philip K.
    Dyhring, Tino
    Peters, Dan
    Harpsoe, Kasper
    Liljefors, Tommy
    Balle, Thomas
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2311 - 2316
  • [28] Non-equivalent Ligand Selectivity of Agonist Sites in (α4β2)2α4 Nicotinic Acetylcholine Receptors A KEY DETERMINANT OF AGONIST EFFICACY
    Mazzaferro, Simone
    Gasparri, Federica
    New, Karina
    Alcaino, Constanza
    Faundez, Manuel
    Iturriaga Vasquez, Patricio
    Vijayan, Ranjit
    Biggin, Philip C.
    Bermudez, Isabel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (31) : 21795 - 21806
  • [29] Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins
    Cuny, Hartmut
    Kompella, Shiva N.
    Tae, Han-Shen
    Yu, Rilei
    Adams, David J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (45) : 23779 - 23792
  • [30] Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line:: Pharmacology of ligand binding and function
    Xiao, YX
    Meyer, EL
    Thompson, JM
    Surin, A
    Wroblewski, J
    Kellar, KJ
    MOLECULAR PHARMACOLOGY, 1998, 54 (02) : 322 - 333
12345